- Home
- HRZN vs CMPX Comparison
HRZN vs CMPX Comparison
Compare HRZN & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRZN
- CMPX
- Stock Information
- Founded
- HRZN 2008
- CMPX 2014
- Country
- HRZN United States
- CMPX United States
- Employees
- HRZN N/A
- CMPX N/A
- Industry
- HRZN Finance/Investors Services
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- HRZN Finance
- CMPX Health Care
- Exchange
- HRZN Nasdaq
- CMPX Nasdaq
- Market Cap
- HRZN 352.9M
- CMPX 291.8M
- IPO Year
- HRZN 2010
- CMPX N/A
- Fundamental
- Price
- HRZN $7.43
- CMPX $2.26
- Analyst Decision
- HRZN Hold
- CMPX Strong Buy
- Analyst Count
- HRZN 5
- CMPX 8
- Target Price
- HRZN $9.20
- CMPX $13.13
- AVG Volume (30 Days)
- HRZN 494.7K
- CMPX 804.3K
- Earning Date
- HRZN 07-29-2025
- CMPX 05-08-2025
- Dividend Yield
- HRZN 17.77%
- CMPX N/A
- EPS Growth
- HRZN N/A
- CMPX N/A
- EPS
- HRZN N/A
- CMPX N/A
- Revenue
- HRZN $98,302,000.00
- CMPX $850,000.00
- Revenue This Year
- HRZN $1.42
- CMPX N/A
- Revenue Next Year
- HRZN $4.42
- CMPX N/A
- P/E Ratio
- HRZN N/A
- CMPX N/A
- Revenue Growth
- HRZN N/A
- CMPX N/A
- 52 Week Low
- HRZN $7.12
- CMPX $0.77
- 52 Week High
- HRZN $12.63
- CMPX $4.08
- Technical
- Relative Strength Index (RSI)
- HRZN 41.24
- CMPX 57.21
- Support Level
- HRZN $7.29
- CMPX $2.06
- Resistance Level
- HRZN $7.60
- CMPX $2.26
- Average True Range (ATR)
- HRZN 0.12
- CMPX 0.12
- MACD
- HRZN 0.04
- CMPX 0.01
- Stochastic Oscillator
- HRZN 53.06
- CMPX 50.00
About HRZN Horizon Technology Finance Corporation
Horizon Technology Finance Corp is a specialty finance company. Its investment objective is to maximize its investment portfolio's total return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. It lends to and invests in development-stage companies in the technology, life science, healthcare information and services, and sustainability industries.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.